Diferencia entre revisiones de «EBQ:End-Tidal CO2 Monitoring»
| Línea 20: | Línea 20: | ||
ETCO₂ monitoring identified the majority of acute respiratory events during PSA, and in 70% of these cases, abnormalities were detected before clinical recognition via SpO₂ or observed hypoventilation. ETCO₂ monitoring offers earlier detection of respiratory compromise than current standard practices. | ETCO₂ monitoring identified the majority of acute respiratory events during PSA, and in 70% of these cases, abnormalities were detected before clinical recognition via SpO₂ or observed hypoventilation. ETCO₂ monitoring offers earlier detection of respiratory compromise than current standard practices. | ||
==Major Points== | ==Major Points== | ||
33% of PSA encounters included acute respiratory events. | |||
85% of those with respiratory events had abnormal ETCO₂ findings. | |||
In 70% of events, abnormal ETCO₂ was recorded before observed clinical signs. | |||
Many ETCO₂ abnormalities were not associated with interventions, suggesting possible transient or clinically insignificant episodes. | |||
Use of capnography may enhance detection of early hypoventilation or apnea and improve patient safety during PSA. | |||
==Study Design== | ==Study Design== | ||
Revisión del 03:21 4 may 2025
PubMed Full text PDF
Clinical Question
Can end-tidal carbon dioxide (ETCO₂) monitoring during emergency department procedural sedation and analgesia (PSA) detect acute respiratory events earlier than standard monitoring methods (e.g., SpO₂, clinical observation)?
Conclusion
ETCO₂ monitoring identified the majority of acute respiratory events during PSA, and in 70% of these cases, abnormalities were detected before clinical recognition via SpO₂ or observed hypoventilation. ETCO₂ monitoring offers earlier detection of respiratory compromise than current standard practices.
Major Points
33% of PSA encounters included acute respiratory events.
85% of those with respiratory events had abnormal ETCO₂ findings.
In 70% of events, abnormal ETCO₂ was recorded before observed clinical signs.
Many ETCO₂ abnormalities were not associated with interventions, suggesting possible transient or clinically insignificant episodes.
Use of capnography may enhance detection of early hypoventilation or apnea and improve patient safety during PSA.
